WO1997014961A1 - Procede de diagnostic de troubles oncologiques - Google Patents

Procede de diagnostic de troubles oncologiques Download PDF

Info

Publication number
WO1997014961A1
WO1997014961A1 PCT/RU1995/000225 RU9500225W WO9714961A1 WO 1997014961 A1 WO1997014961 A1 WO 1997014961A1 RU 9500225 W RU9500225 W RU 9500225W WO 9714961 A1 WO9714961 A1 WO 9714961A1
Authority
WO
WIPO (PCT)
Prior art keywords
κροvi
analysis
sπeκτρalny
identifies
chτο
Prior art date
Application number
PCT/RU1995/000225
Other languages
English (en)
Russian (ru)
Inventor
Alexandr Nikolaevich Antipov
Vladislav Fedorovich Lamekin
Evgeny Dmitrievich Pozhidaev
Dingir Dmitrievich Pak
Anatoly Pavlovich Orlov
Original Assignee
Aktsionernoe Obschestvo Zakrytogo Tipa 'ntf Intersvyaz'
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktsionernoe Obschestvo Zakrytogo Tipa 'ntf Intersvyaz' filed Critical Aktsionernoe Obschestvo Zakrytogo Tipa 'ntf Intersvyaz'
Priority to PCT/RU1995/000225 priority Critical patent/WO1997014961A1/fr
Publication of WO1997014961A1 publication Critical patent/WO1997014961A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light

Definitions

  • the invention is related to medicine, and more precisely, it relates to methods of diagnosing an oncologic disease.
  • the known method of diagnosis is relied on for the molecular methods of analysis, and the analysis requires the use of a large, large volume of patient's plasma.
  • the well-known method of accessing the device is a non-hazardous, non-radiant device that does not require a high sensitivity.
  • a quick task is to identify the benefits of absorption associated with cancer.
  • ⁇ as ⁇ y ⁇ ie iz ⁇ b ⁇ e ⁇ eniya May 3 ⁇ sn ⁇ vu iz ⁇ b ⁇ e ⁇ eniya ⁇ l ⁇ zhena task s ⁇ zdas ⁇ s ⁇ - s ⁇ b diagn ⁇ s ⁇ i ⁇ i ⁇ n ⁇ l ⁇ giches ⁇ i ⁇ zab ⁇ levaniy.
  • ⁇ zv ⁇ lyayuschy ⁇ i is ⁇ lz ⁇ vanii neznachi ⁇ eln ⁇ g ⁇ ⁇ liches ⁇ va ⁇ vi with vys ⁇ y chuvs ⁇ vi ⁇ eln ⁇ s ⁇ yu iden ⁇ i ⁇ itsi ⁇ va ⁇ ⁇ n ⁇ l ⁇ giches- ⁇ ie zab ⁇ levaniya ⁇ a ⁇ n ⁇ v ⁇ zhdenyay ⁇ y, and y ⁇ a ⁇ vz ⁇ sly ⁇ 0 to ⁇ anney s ⁇ adii
  • the methods of diagnosis of the oncologic disease includes a surgical analysis of the disease and the outcome of the disease.
  • ⁇ e ⁇ d ⁇ SH0 not is ⁇ lz ⁇ valsya ⁇ anee for diagn ⁇ s ⁇ i- ⁇ i ⁇ L ⁇ ICH ⁇ S ⁇ I ⁇ zab ⁇ l ⁇ vany and is ⁇ lz ⁇ valsya ⁇ i used sled ⁇ vanii ⁇ imiches ⁇ i ⁇ s ⁇ ediyaeny in ⁇ izi ⁇ e ⁇ ve ⁇ d ⁇ g ⁇ ⁇ e- la (H ⁇ a ⁇ i ⁇ . "S ⁇ e ⁇ s ⁇ iya vnu ⁇ enneg ⁇ ⁇ azheniya" ⁇ e ⁇ .s angl.iz-v ⁇ " ⁇ i ⁇ ” M. , 1970).
  • the device for the implementation of the proposed method contains a source of I radiation, a large amount of 2 components, and a two-phase error of 4–1. ⁇ 97/14961 ⁇ / ⁇ 95 / 00225
  • PRISM 3 is compensatory, and PRIMISM 4 is operational, at first, RESEARCHES or plasma are applied.
  • Prisms 3 and 4 may be taken from cadmium sulfide, brown, germanium and others.
  • working surfaces 4 contain a thin layer of plasma or circle, taken from a patient.
  • 0m is ⁇ chni ⁇ a I izluch ⁇ niya two ⁇ a ⁇ all ⁇ lyga ⁇ beam in ⁇ a ⁇ asn ⁇ g ⁇ izluch ⁇ niya ⁇ s ⁇ u ⁇ ayu ⁇ ze ⁇ ala at 5-2 and 6-2, ⁇ azhayu ⁇ sya ⁇ z ⁇ al 5-1 and 6-1, s ⁇ v ⁇ s ⁇ v ⁇ nn ⁇ and na ⁇ avlyayu ⁇ sya on v ⁇ dnye g ⁇ ani ⁇ izm 3 and 4.
  • steps 3 and 4 are made from cadmium sulfide, brown, germanium.
  • EXAMPLE I In a healthy person (donor), 0.05 ml of the mixture is taken from the skin and applied to the body of the product 4. I would like to accept 4 in the 4P ⁇ program, which is also used in a crypto unit and is protected by a device. ⁇ ⁇ luch ⁇ nn ⁇ m s ⁇ ( ⁇ ig.2) ⁇ bna ⁇ uzh ⁇ ny I ⁇ SI ⁇ Y ⁇ C vys ⁇ im ⁇ az ⁇ sh ⁇ ni ⁇ m, ⁇ l ⁇ sy ⁇ gl ⁇ scheniya, ⁇ inadlezha ⁇ she ⁇ vi. Approximate ⁇ 2.

Landscapes

  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

Cette invention concerne un procédé de diagnostic de troubles oncologiques, lequel procédé consiste à effectuer une analyse spectrale du sang d'après le processus de réflexion interne, totale, irrégulière et multiple dans la région infrarouge (IR) du spectre, et à déceler la maladie dans une plage de fréquences allant de 850 cm-1 à 4000 cm-1.
PCT/RU1995/000225 1995-10-18 1995-10-18 Procede de diagnostic de troubles oncologiques WO1997014961A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/RU1995/000225 WO1997014961A1 (fr) 1995-10-18 1995-10-18 Procede de diagnostic de troubles oncologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1995/000225 WO1997014961A1 (fr) 1995-10-18 1995-10-18 Procede de diagnostic de troubles oncologiques

Publications (1)

Publication Number Publication Date
WO1997014961A1 true WO1997014961A1 (fr) 1997-04-24

Family

ID=20129958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU1995/000225 WO1997014961A1 (fr) 1995-10-18 1995-10-18 Procede de diagnostic de troubles oncologiques

Country Status (1)

Country Link
WO (1) WO1997014961A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749565B2 (en) 2000-07-08 2004-06-15 Victor Chudner Method for blood infrared spectroscopy diagnosing of inner organs pathology
EP1640036A1 (fr) * 2004-09-23 2006-03-29 Heinz Grundmeyer Procédure bioénergétique de diagnostic
US9664680B2 (en) 2012-11-15 2017-05-30 University Of Central Lancashire Methods of diagnosing proliferative disorders
WO2018188763A1 (fr) 2017-04-14 2018-10-18 Cosma S.P.A. Nouveau procédé pour la synthèse de firocoxib

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014134A1 (fr) * 1991-02-04 1992-08-20 National Research Council Of Canada Procede permettant de detecter la presence d'anomalies dans des cellules exfoliees par spectroscopie a infrarouge
US5168162A (en) * 1991-02-04 1992-12-01 Cornell Research Foundation, Inc. Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy
RU2000027C1 (ru) * 1991-12-27 1993-02-15 Галина Петровна Петрова Способ диагностики онкологических заболеваний

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014134A1 (fr) * 1991-02-04 1992-08-20 National Research Council Of Canada Procede permettant de detecter la presence d'anomalies dans des cellules exfoliees par spectroscopie a infrarouge
US5168162A (en) * 1991-02-04 1992-12-01 Cornell Research Foundation, Inc. Method of detecting the presence of anomalies in exfoliated cells using infrared spectroscopy
RU2000027C1 (ru) * 1991-12-27 1993-02-15 Галина Петровна Петрова Способ диагностики онкологических заболеваний

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749565B2 (en) 2000-07-08 2004-06-15 Victor Chudner Method for blood infrared spectroscopy diagnosing of inner organs pathology
EP1640036A1 (fr) * 2004-09-23 2006-03-29 Heinz Grundmeyer Procédure bioénergétique de diagnostic
US9664680B2 (en) 2012-11-15 2017-05-30 University Of Central Lancashire Methods of diagnosing proliferative disorders
US10288615B2 (en) 2012-11-15 2019-05-14 University Of Central Lancashire Methods of diagnosing proliferative disorders
WO2018188763A1 (fr) 2017-04-14 2018-10-18 Cosma S.P.A. Nouveau procédé pour la synthèse de firocoxib

Similar Documents

Publication Publication Date Title
JP3129956B2 (ja) 非侵襲性の身体の化学的性質を決定する装置
ES2712200T3 (es) Método para medir una respuesta de muestra espectral
JP3212996B2 (ja) 生体内の血糖レベルを測定するための装置
US6889069B2 (en) Non-invasive measurement of blood analytes using photodynamics
CA2544204C (fr) Determination d'une mesure d'un produit final de glycation ou d'un etat pathologique a l'aide de la fluorescence tissulaire
US8238993B2 (en) Determination of a measure of a glycation end-product or disease state using tissue fluorescence lifetime
US5640957A (en) Ultraviolet radiation protection evaluator
JP2000507349A (ja) 光学活性化合物の非侵襲的測定
JPH07500030A (ja) 目のレンズにおける分子変化の測定
US20050288564A1 (en) Method and apparatus for performing in-vivo blood analysis using raman spectrum
JP2000500374A (ja) 人体組織または体液中の物質の経皮的測定
RU2501515C2 (ru) Способ оптического обнаружения и устройство для оптического обнаружения состояния суставов
WO1997014961A1 (fr) Procede de diagnostic de troubles oncologiques
Naumova et al. Historical review of early researches on mitogenetic radiation: from discovery to cancer diagnostics
Hergenroeder et al. Increased levels of circulating glial fibrillary acidic protein and collapsin response mediator protein-2 autoantibodies in the acute stage of spinal cord injury predict the subsequent development of neuropathic pain
Wu et al. Narrow‐band UVB irradiation stimulates the migration and functional development of vitiligo‐IgG antibodies‐treated pigment cells
Haimid et al. Helium-Neon Laser Effects on Human Whole Blood by Spectroscopy In vitro Study
EP1161924A4 (fr) Procede de diagnostic de regions de proliferation et dispositif de mise en oeuvre de ce procede
Harris et al. Emerging Eye-Based Diagnostic Technologies for Traumatic Brain Injury
Ono et al. Local inflammation exacerbates cutaneous manifestations in a murine autoimmune pemphigus model
US20040267101A1 (en) Method and device for the detection of substances in vital tissue
Eikje et al. Identification and characterization of skin biomolecules for drug targeting and monitoring by vibrational spectroscopy
RU2121143C1 (ru) Способ для обнаружения и оценки концентрации анаэробных бактерий в биологическом субстрате
Yoon et al. Optical measurement of glucose levels in scattering media
RU2488825C2 (ru) Способ диагностики травм глаза

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): BY CA CH CN DE DK EE ES FI GB JP KR KZ MX SE UA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97515723

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA